[HIGHLIGHTS] National Medical Insurance Administration: Focus on the treatment of new coronary pneumonia drugs and release signals to encourage innovation
2020-08-28T23:28:13.673Z
Read the full translated version in English
Read the full version from chinanews
The information on this site is from external sources that are not under our control. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.